JP5184840B2 - Topical skin preparation - Google Patents
Topical skin preparation Download PDFInfo
- Publication number
- JP5184840B2 JP5184840B2 JP2007202774A JP2007202774A JP5184840B2 JP 5184840 B2 JP5184840 B2 JP 5184840B2 JP 2007202774 A JP2007202774 A JP 2007202774A JP 2007202774 A JP2007202774 A JP 2007202774A JP 5184840 B2 JP5184840 B2 JP 5184840B2
- Authority
- JP
- Japan
- Prior art keywords
- ogi
- extract
- formulation
- added
- ground part
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title description 9
- 230000000699 topical effect Effects 0.000 title 1
- 239000000284 extract Substances 0.000 claims description 35
- 230000002087 whitening effect Effects 0.000 claims description 7
- 239000002537 cosmetic Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims 1
- 235000006533 astragalus Nutrition 0.000 description 41
- 238000004519 manufacturing process Methods 0.000 description 33
- 239000000203 mixture Substances 0.000 description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 238000009472 formulation Methods 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 22
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 18
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 239000000047 product Substances 0.000 description 13
- 229940058015 1,3-butylene glycol Drugs 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 235000019437 butane-1,3-diol Nutrition 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- -1 lipid peroxides Chemical class 0.000 description 10
- 239000008213 purified water Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000000469 ethanolic extract Substances 0.000 description 9
- 239000008346 aqueous phase Substances 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 230000008099 melanin synthesis Effects 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 241000219051 Fagopyrum Species 0.000 description 4
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 244000075850 Avena orientalis Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 241001061264 Astragalus Species 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003788 bath preparation Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 2
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000010977 jade Substances 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、オウギ地上部の抽出物を含有することを特徴とする老化防止と美白作用に優れた皮膚外用剤に関する。 The present invention relates to a skin external preparation excellent in anti-aging and whitening action, characterized by containing an extract from the upper part of ogi.
近年、生体成分を酸化させる要因として、フリーラジカルや活性酸素がとりあげられ、その悪影響が問題となっている。フリーラジカルや活性酸素は、生体内で生じ、コラーゲン等の生体組織を分解あるいは架橋し、また、脂質を酸化して、細胞に傷害を与える過酸化脂質をつくると言われている。この様な傷害は、肌のシワやハリが低下する等の老化の原因になると考えられており、老化を防ぐ方法の一つにフリーラジカルや活性酸素を除去する抗酸化剤を配合する方法が知られている。従来、老化防止を目的として用いられるフリーラジカル消去剤にはアスコルビン酸、トコフェロール、3,5−tert−ブチル−4−ヒドロキシトルエン(BHT)、スーパーオキシドジスムターゼ(SOD)等が用いられてきた。 In recent years, free radicals and active oxygen have been taken up as factors that oxidize biological components, and their adverse effects have become a problem. Free radicals and active oxygen are said to be generated in vivo and decompose or crosslink biological tissues such as collagen, and oxidize lipids to produce lipid peroxides that damage cells. Such injuries are thought to cause aging such as wrinkles and firmness of the skin, and one method for preventing aging is to incorporate an antioxidant that removes free radicals and active oxygen. Are known. Conventionally, ascorbic acid, tocopherol, 3,5-tert-butyl-4-hydroxytoluene (BHT), superoxide dismutase (SOD) and the like have been used as free radical scavengers used for the purpose of preventing aging.
一般にシミ、ソバカス、日焼け等に見られる皮膚の色素沈着は、ホルモンの異常や紫外線の刺激により、皮膚内に存在するメラニン色素生成細胞がメラニン色素を過剰に生成し、これが皮膚内に沈着することが原因と考えられている。このような色素沈着を防ぐ方法の一つに、メラニンの過剰な生成を抑制する方法が知られている。従来、色素沈着の治療にはハイドロキノンやアスコルビン酸等を外用する処置が行われてきた。 In general, pigmentation of the skin seen in spots, buckwheat, sunburn, etc. is caused by excessive melanin pigment formation by melanin-producing cells present in the skin due to hormonal abnormalities or stimulation of ultraviolet rays, which deposits in the skin. Is considered to be the cause. As one method for preventing such pigmentation, a method for suppressing excessive production of melanin is known. Conventionally, treatments for external application of hydroquinone, ascorbic acid or the like have been performed for the treatment of pigmentation.
オウギはその根(黄耆)が漢方薬によく用いられ、化粧料にも応用されている(特許文献1)。しかし、オウギの地上部は化粧品への応用例はなく、特に、抗酸化作用やメラニン生成抑制作用は検討されていない。
皮膚の老化防止又は抗酸化を目的として用いられるSODは不安定であり、製剤化が難しく、トコフェロールも効果が充分であるとは言えない。また、合成化合物であるBHT等は安全性に問題があり、配合量に制限があることから、化学合成品ではなく、安定でかつ副作用が少ないとともにより効果の高い天然原料が望まれている。美白剤して用いられるアスコルビン酸は経時的に分解しやすい等の欠点があるため、また、ハイドロキノンは安全性に問題があるため、より安全で安定性が高く、より効果の優れた天然物由来の原料が望まれている。 SOD used for the purpose of preventing skin aging or anti-oxidation is unstable, difficult to formulate, and tocopherol is not effective enough. Moreover, since BHT etc. which are synthetic compounds have a problem in safety | security and there exists a restriction | limiting in compounding quantity, it is not a chemically synthesized product but the natural raw material which is stable and has few side effects, and is more effective is desired. Ascorbic acid used as a whitening agent has disadvantages such as being easily decomposed over time, and hydroquinone has safety problems, so it is safer, more stable, and more effective. The raw material of is desired.
このような事情により、本発明者らは鋭意検討した結果、オウギ地上部の抽出物が優れた抗酸化作用及びメラニン生成抑制作用をもち、安定性においても優れていることを見出した。さらに、その抽出物を含有する皮膚外用剤が、安全で安定であり、老化防止及び美白作用に優れていることを見出し、本発明を完成するに至った。 Under such circumstances, the present inventors have intensively studied, and as a result, have found that the extract of the above-ground part of ogi has an excellent anti-oxidant action and melanin production-inhibiting action and is also excellent in stability. Furthermore, it discovered that the skin external preparation containing the extract was safe and stable, and was excellent in anti-aging and whitening effect, and came to complete this invention.
本発明に用いるオウギ(マメ科)は、キバナオウギ Astragalus membranaceus(アストラガルス メンブラナセウス)及びナイモウオウギ Astragalus mongholicus(アストラガルス モンゴリカス)であり、その地上部を用いることができる。その地上部には、葉、茎、花及び実が含まれる。そのオウギ地上部は、健康食品用として流通しているものを利用することができる。 The sea urchin (Leguminosae) used in the present invention is Astragalus membranaceus (Astragalus membranaceus) and Astragalus mongolicus (Astragalus mongolicus), and the above-ground part can be used. The aerial part includes leaves, stems, flowers and fruits. The ground part of the ogi can be used for health foods.
本発明に用いるオウギ地上部の抽出物の抽出方法は、特に限定されず、例えば、加熱抽出したものであっても良いし、常温抽出したものであっても良い。 The extraction method of the extract of the above-ground ogi used for this invention is not specifically limited, For example, what was extracted by heating and normal temperature extraction may be used.
抽出する溶媒としては、例えば、水、低級アルコール類(メタノール、エタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール等)、液状多価アルコール(1,3−ブチレングリコール、プロピレングリコール、グリセリン等)、ケトン類(アセトン、メチルエチルケトン等)、アセトニトリル、エステル類(酢酸エチル、酢酸ブチル等)、炭化水素類(ヘキサン、ヘプタン、流動パラフィン等)、エーテル類(エチルエーテル、テトラヒドロフラン、プロピルエーテル等)が挙げられる。好ましくは、水、低級アルコール及び液状多価アルコール等の極性溶媒が良く、特に好ましくは、水、エタノール、1,3−ブチレングリコール及びプロピレングリコールが良い。これらの溶媒は一種でも二種以上を混合して用いても良い。 Examples of the solvent to be extracted include water, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohols (1,3-butylene glycol, propylene glycol). , Glycerin, etc.), ketones (acetone, methyl ethyl ketone, etc.), acetonitrile, esters (ethyl acetate, butyl acetate, etc.), hydrocarbons (hexane, heptane, liquid paraffin, etc.), ethers (ethyl ether, tetrahydrofuran, propyl ether) Etc.). Preferred are polar solvents such as water, lower alcohols and liquid polyhydric alcohols, and particularly preferred are water, ethanol, 1,3-butylene glycol and propylene glycol. These solvents may be used alone or in combination of two or more.
上記抽出物は、抽出した溶液のまま用いても良く、必要に応じて、濃縮、希釈及び濾過処理、活性炭等による脱色、脱臭処理等をして用いても良い。更には、抽出した溶液を濃縮乾固、噴霧乾燥、凍結乾燥等の処理を行い、乾燥物として用いても良い。 The extract may be used as it is, or may be used after concentration, dilution and filtration treatment, decolorization with activated carbon, deodorization treatment, or the like, if necessary. Further, the extracted solution may be subjected to a treatment such as concentration to dryness, spray drying, freeze drying, etc., and used as a dried product.
本発明の皮膚外用剤には、上記抽出物をそのまま使用しても良く、抽出物の効果を損なわない範囲内で、外用剤に用いられる成分である油脂類、ロウ類、炭化水素類、脂肪酸類、アルコール類、エステル類、界面活性剤、金属石鹸、pH調整剤、防腐剤、香料、保湿剤、粉体、紫外線吸収剤、増粘剤、色素、酸化防止剤、美白剤、キレート剤等の成分を配合することができる。 In the external preparation for skin of the present invention, the above extract may be used as it is, and within the range not impairing the effect of the extract, oils and fats, waxes, hydrocarbons, fatty acids which are components used in the external preparation , Alcohols, esters, surfactants, metal soaps, pH adjusters, preservatives, fragrances, moisturizers, powders, UV absorbers, thickeners, pigments, antioxidants, whitening agents, chelating agents, etc. These components can be blended.
本発明の皮膚外用剤は、化粧品、医薬部外品、医薬品のいずれにも用いることができ、その剤形としては、例えば、化粧水、クリ−ム、乳液、ゲル剤、エアゾール剤、エッセンス、パック、洗浄剤、浴用剤、ファンデ−ション、打粉、口紅、軟膏、パップ剤等の皮膚に適用されるものが挙げられる。 The external preparation for skin of the present invention can be used for any of cosmetics, quasi drugs, and pharmaceuticals. Examples of the dosage form include skin lotions, creams, emulsions, gels, aerosols, essences, Examples include packs, cleaning agents, bath preparations, foundations, dusting powders, lipsticks, ointments, and poultices applied to the skin.
本発明に用いる上記抽出物の配合量は、本発明の皮膚外用剤全量に対し、固形物に換算して0.0001重量%以上、好ましくは0.001〜10重量%の配合が良い。0.0001重量%未満では十分な効果は望みにくい。10重量%を越えて配合した場合、効果の増強は認められにくく不経済である。また、添加の方法については、予め加えておいても、製造途中で添加しても良く、作業性を考えて適宜選択すれば良い。 The amount of the extract used in the present invention is 0.0001% by weight or more, preferably 0.001 to 10% by weight in terms of solid matter, based on the total amount of the external preparation for skin of the present invention. If it is less than 0.0001% by weight, a sufficient effect is hardly expected. When the blending amount exceeds 10% by weight, the effect is hardly recognized and it is uneconomical. In addition, the addition method may be added in advance or during the production, and may be appropriately selected in consideration of workability.
本発明のオウギ地上部の抽出物は、その根の抽出物よりも優れたDPPHラジカル消去作用、メラニン生成抑制作用を有し、安定性にも優れていた。さらに、その抽出物を含有する皮膚外用剤は、安全で優れた老化防止及び美白作用を示した。 The above-ground extract of the ogi of the present invention had a DPPH radical scavenging action and a melanin production-inhibiting action superior to the root extract, and was also excellent in stability. Furthermore, the skin external preparation containing the extract showed safe and excellent anti-aging and whitening action.
次に本発明を詳細に説明するため、実施例として本発明に用いる抽出物の製造例、本発明の処方例及び実験例を挙げるが、本発明はこれに限定されるものではない。処方例に示す配合量の部とは重量部を、%とは重量%を示す。 Next, in order to describe the present invention in detail, examples of producing the extract used in the present invention, formulation examples and experimental examples of the present invention will be given as examples, but the present invention is not limited thereto. The part of the compounding amount shown in the prescription example means part by weight, and% means weight%.
製造例1 オウギ地上部の熱水抽出物
オウギ地上部の乾燥物20gに精製水400mLを加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥してオウギ地上部の熱水抽出物を3.7g得た。
Production Example 1 Hot water extract of above-ground part of ogi 400 ml of purified water was added to 20 g of dried product of above-ground part of ogi, extracted at 95-100 ° C. for 2 hours, filtered, and the filtrate was concentrated, freeze-dried and dried. 3.7g of hot water extract of the above-ground part was obtained.
製造例2 オウギ地上部の50%エタノール抽出物
オウギ地上部の乾燥物20gに50(v/v)%エタノール水溶液400mLを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、オウギ地上部の50%エタノール抽出物を2.6g得た。
Production Example 2 50% ethanol extract of above-ground part of ogi 400 mL of 50 (v / v)% aqueous ethanol solution was added to 20 g of dried product of above-ground part of ogi, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness. As a result, 2.6 g of 50% ethanol extract of the above-ground part of the ogi was obtained.
製造例3 オウギ地上部の50%1,3−ブチレングリコール抽出物
オウギ地上部の乾燥物20gに精製水200g及び1,3−ブチレングリコール200gを加え、常温で7日間抽出した後、濾過し、オウギ地上部の50%1,3−ブチレングリコール抽出物を360g得た。
Production Example 3 50% 1,3-butylene glycol extract of the above-ground part of the ogi 200 g of purified water and 200 g of 1,3-butylene glycol were added to 20 g of the dried product of the above-ground part of the ogi, followed by extraction at room temperature for 7 days, followed by filtration. 360 g of 50% 1,3-butylene glycol extract of the above-ground part of ogi was obtained.
比較製造例1 オウギ根の熱水抽出物
オウギ根の乾燥物(黄耆)20gに精製水400mLを加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥してオウギ根の熱水抽出物を4.5g得た。
Comparative Production Example 1 Hot water extract of ogi roots 400 mL of purified water was added to 20 g of dried ogi roots (yellow jade), extracted at 95-100 ° C. for 2 hours, filtered, and the filtrate was concentrated and lyophilized. As a result, 4.5 g of hot water extract of oat root was obtained.
比較製造例2 オウギ根の50%エタノール抽出物
オウギ根の乾燥物(黄耆)20gに50(v/v)%エタノール水溶液400mLを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、オウギ根の50%エタノール抽出物を5.1g得た。
Comparative Production Example 2 50% Ethanol Extract of Ogi Root 400 mL of 50 (v / v)% ethanol aqueous solution was added to 20 g of dried dried ogi root (yellow jade), extracted at room temperature for 7 days, filtered, and the filtrate was filtered. Concentration to dryness yielded 5.1 g of 50% ethanol extract of oat root.
処方例1 化粧水
処方 配合量
1.オウギ地上部の熱水抽出物(製造例1) 0.1部
2.1,3−ブチレングリコール 8.0
3.グリセリン 2.0
4.キサンタンガム 0.02
5.クエン酸 0.01
6.クエン酸ナトリウム 0.1
7.エタノール 5.0
8.パラオキシ安息香酸メチル 0.1
9.ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.1
10.香料 適量
11.精製水にて全量を100とする
[製造方法]成分1〜6及び11と、成分7〜10をそれぞれ均一に溶解し、両者を混合し濾過して製品とする。
Formulation Example 1 Lotion Formulation Amount Hot water extract of above-ground ogi (Production Example 1) 0.1 part 2.1,3-butylene glycol 8.0
3. Glycerin 2.0
4). Xanthan gum 0.02
5. Citric acid 0.01
6). Sodium citrate 0.1
7). Ethanol 5.0
8). Methyl paraoxybenzoate 0.1
9. Polyoxyethylene hydrogenated castor oil (40E.O.) 0.1
10. Perfume
11. [Manufacturing method] Components 1 to 6 and 11 and components 7 to 10 are uniformly dissolved in purified water, and both are mixed and filtered to obtain a product.
比較例1 従来の化粧水
処方例1において、オウギ地上部の熱水抽出物(製造例1)をオウギ根の熱水抽出物(比較製造例1)に置き換えたものを従来の化粧水とした。
Comparative Example 1 Conventional lotion In Formulation Example 1, the hot water extract of the above-ground part of Ogi (Production Example 1) was replaced with the hot water extract of ogi root (Comparative Production Example 1) to obtain a conventional lotion. .
処方例2 クリーム
処方 配合量
1.オウギ地上部の50%エタノール抽出物(製造例2) 0.05部
2.スクワラン 5.5
3.オリーブ油 3.0
4.ステアリン酸 2.0
5.ミツロウ 2.0
6.ミリスチン酸オクチルドデシル 3.5
7.ポリオキシエチレンセチルエーテル(20E.O.) 3.0
8.ベヘニルアルコール 1.5
9.モノステアリン酸グリセリン 2.5
10.香料 0.1
11.パラオキシ安息香酸メチル 0.2
12.パラオキシ安息香酸エチル 0.05
13.1,3−ブチレングリコール 8.5
14.精製水にて全量を100とする
[製造方法]成分2〜9を加熱溶解して混合し、70℃に保ち油相とする。成分1及び11〜14を加熱溶解して混合し、75℃に保ち水相とする。油相に水相を加えて乳化して、かき混ぜながら冷却し、45℃で成分10を加え、更に30℃まで冷却して製品とする。
Formulation Example 2 Cream Formulation Amount 50 parts ethanol extract of the above-ground part of ogi (Production Example 2) 0.05 part Squalane 5.5
3. Olive oil 3.0
4). Stearic acid 2.0
5. Beeswax 2.0
6). Octyldodecyl myristate 3.5
7). Polyoxyethylene cetyl ether (20E.O.) 3.0
8). Behenyl alcohol 1.5
9. Glycerol monostearate2.5
10. Fragrance 0.1
11. Methyl paraoxybenzoate 0.2
12 Ethyl paraoxybenzoate 0.05
13.1,3-Butylene glycol 8.5
14 [Manufacturing method] Components 2 to 9 are heated and dissolved and mixed with purified water to a total amount of 100, and kept at 70 ° C to obtain an oil phase. Ingredients 1 and 11 to 14 are dissolved by heating and mixed, and kept at 75 ° C. to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify, and the mixture is cooled while stirring. The component 10 is added at 45 ° C., and further cooled to 30 ° C. to obtain a product.
比較例2 従来のクリーム
処方例2において、オウギ地上部の50%エタノール抽出物(製造例2)をオウギ根の50%エタノール抽出物(比較製造例2)に置き換えたものを従来のクリームとした。
Comparative Example 2 Conventional Cream In Formulation Example 2, a 50% ethanol extract of the above-ground part of Ogi (Production Example 2) was replaced with a 50% ethanol extract of Ogi root (Comparative Production Example 2) to obtain a conventional cream. .
処方例3 乳液
処方 配合量
1.オウギ地上部の熱水抽出物(製造例1) 0.001部
2.スクワラン 5.0
3.オリーブ油 5.0
4.ホホバ油 5.0
5.セタノール 1.5
6.モノステアリン酸グリセリン 2.0
7.ポリオキシエチレンセチルエーテル(20E.O.) 3.0
8.ポリオキシエチレンソルビタンモノオレエート
(20E.O.) 2.0
9.香料 0.1
10.プロピレングリコール 1.0
11.グリセリン 2.0
12.パラオキシ安息香酸メチル 0.2
13.精製水にて全量を100とする
[製造方法]成分2〜8を加熱溶解して混合し、70℃に保ち油相とする。成分1及び10〜13を加熱溶解して混合し、75℃に保ち水相とする。油相に水相を加えて乳化して、かき混ぜながら冷却し、45℃で成分9を加え、更に30℃まで冷却して製品とする。
Formulation Example 3 Emulsion Formulation Formulation 1. 1. Hot water extract of above-ground part of ogi (Production Example 1) 0.001 part Squalane 5.0
3. Olive oil 5.0
4). Jojoba oil 5.0
5. Cetanol 1.5
6). Glycerol monostearate 2.0
7). Polyoxyethylene cetyl ether (20E.O.) 3.0
8). Polyoxyethylene sorbitan monooleate (20E.O.) 2.0
9. Fragrance 0.1
10. Propylene glycol 1.0
11. Glycerin 2.0
12 Methyl paraoxybenzoate 0.2
13. Make the total volume 100 with purified water
[Manufacturing method] Components 2 to 8 are dissolved by heating and mixed, and kept at 70 ° C to obtain an oil phase. Ingredients 1 and 10-13 are dissolved by heating and mixed, and kept at 75 ° C. to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify, and the mixture is cooled while stirring. The component 9 is added at 45 ° C., and further cooled to 30 ° C. to obtain a product.
処方例4 ゲル剤
処方 配合量
1.オウギ地上部の50%1,3−ブチレングリコール抽出物
(製造例3) 1.0部
2.エタノール 5.0
3.パラオキシ安息香酸メチル 0.1
4.ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.1
5.香料 適量
6.1,3−ブチレングリコール 5.0
7.グリセリン 5.0
8.キサンタンガム 0.1
9.カルボキシビニルポリマー 0.2
10.水酸化カリウム 0.2
11.精製水にて全量を100とする
[製造方法]成分2〜5と、成分1及び6〜11をそれぞれ均一に溶解し、両者を混合して製品とする。
Formulation Example 4 Gel formulation Formulation amount 1. 50% 1,3-butylene glycol extract of aboveground part of ogi (Production Example 3) 1.0 part Ethanol 5.0
3. Methyl paraoxybenzoate 0.1
4). Polyoxyethylene hydrogenated castor oil (60 EO) 0.1
5. Perfume
6.1,3-Butylene glycol 5.0
7). Glycerin 5.0
8). Xanthan gum 0.1
9. Carboxyvinyl polymer 0.2
10. Potassium hydroxide 0.2
11. [Production method] Ingredients 2 to 5 and ingredients 1 and 6 to 11 are uniformly dissolved in purified water, and the two are mixed to obtain a product.
処方例5 パック
処方 配合量
1.オウギ地上部の熱水抽出物(製造例1) 0.1部
2.オウギ地上部の50%エタノール抽出物(製造例2) 0.1
3.ポリビニルアルコール 12.0
4.エタノール 5.0
5.1,3−ブチレングリコール 8.0
6.パラオキシ安息香酸メチル 0.2
7.ポリオキシエチレン硬化ヒマシ油(20E.O.) 0.5
8.クエン酸 0.1
9.クエン酸ナトリウム 0.3
10.香料 適量
11.精製水にて全量を100とする
[製造方法]成分1〜11を均一に溶解し製品とする。
Formulation Example 5 Pack Formulation Formulation 1. 1. Hot water extract from above-ground part of ogi (Production Example 1) 0.1 part 50% ethanol extract of above-ground part of ogi (Production Example 2) 0.1
3. Polyvinyl alcohol 12.0
4). Ethanol 5.0
5.1,3-Butylene glycol 8.0
6). Methyl paraoxybenzoate 0.2
7). Polyoxyethylene hydrogenated castor oil (20 EO) 0.5
8). Citric acid 0.1
9. Sodium citrate 0.3
10. Perfume proper amount11. [Production Method] Components 1 to 11 are uniformly dissolved in purified water to make a total amount of 100 to obtain a product.
処方例6 ファンデーション
処方 配合量
1.オウギ地上部の50%エタノール抽出物(製造例2) 1.0部
2.ステアリン酸 2.4
3.ポリオキシエチレンソルビタンモノステアレート
(20E.O.) 1.0
4.ポリオキシエチレンセチルエーテル(20E.O.) 2.0
5.セタノール 1.0
6.液状ラノリン 2.0
7.流動パラフィン 3.0
8.ミリスチン酸イソプロピル 6.5
9.カルボキシメチルセルロースナトリウム 0.1
10.ベントナイト 0.5
11.プロピレングリコール 4.0
12.トリエタノールアミン 1.1
13.パラオキシ安息香酸メチル 0.2
14.二酸化チタン 8.0
15.タルク 4.0
16.ベンガラ 1.0
17.黄酸化鉄 2.0
18.香料 適量
19.精製水にて全量を100とする
[製造方法]成分2〜8を加熱溶解し、80℃に保ち油相とする。成分19に成分9をよく膨潤させ、続いて、成分1及び10〜13を加えて均一に混合する。これに粉砕機で粉砕混合した成分14〜17を加え、ホモミキサーで撹拌し75℃に保ち水相とする。この水相に油相をかき混ぜながら加え、冷却し、45℃で成分18を加え、かき混ぜながら30℃まで冷却して製品とする。
Formulation Example 6 Foundation Formulation Amount 1. 50 parts of 50% ethanol extract of above-ground ogi (Production Example 2) Stearic acid 2.4
3. Polyoxyethylene sorbitan monostearate (20EO) 1.0
4). Polyoxyethylene cetyl ether (20E.O.) 2.0
5. Cetanol 1.0
6). Liquid lanolin 2.0
7). Liquid paraffin 3.0
8). Isopropyl myristate 6.5
9. Sodium carboxymethylcellulose 0.1
10. Bentonite 0.5
11. Propylene glycol 4.0
12 Triethanolamine 1.1
13. Methyl paraoxybenzoate 0.2
14 Titanium dioxide 8.0
15. Talc 4.0
16. Bengala 1.0
17. Yellow iron oxide 2.0
18. Perfume proper amount19. [Manufacturing method] Components 2 to 8 are heated and dissolved in purified water to a total amount of 100, and kept at 80 ° C to obtain an oil phase. Swell component 9 well in component 19, then add components 1 and 10-13 and mix uniformly. To this, components 14 to 17 pulverized and mixed with a pulverizer are added, and the mixture is stirred with a homomixer and kept at 75 ° C. to obtain an aqueous phase. The oil phase is added to this aqueous phase with stirring, cooled, component 18 is added at 45 ° C., and cooled to 30 ° C. with stirring to give a product.
処方例7 浴用剤
処方 配合量
1.オウギ地上部の熱水抽出物(製造例1) 5.0部
2.炭酸水素ナトリウム 50.0
3.黄色202号(1) 適量
4.香料 適量
5.硫酸ナトリウムにて全量を100とする
[製造方法]成分1〜5を均一に混合し製品とする。
Formulation Example 7 Bath preparation formulation 1. Hot water extract of above-ground part of ogi (Production Example 1) 5.0 parts Sodium bicarbonate 50.0
3. Yellow No. 202 (1) Appropriate amount 4. Perfume appropriate amount 5. [Manufacturing method] Ingredients 1 to 5 are mixed uniformly with sodium sulfate to make a product.
処方例8 軟膏
処方 配合量
1.オウギ地上部の熱水抽出物(製造例1) 0.01部
2.オウギ地上部の50%1,3−ブチレングリコール抽出物
(製造例3) 0.5
3.ポリオキシエチレンセチルエーテル(30E.O.) 2.0
4.モノステアリン酸グリセリン 10.0
5.流動パラフィン 5.0
6.セタノール 6.0
7.パラオキシ安息香酸メチル 0.1
8.プロピレングリコール 10.0
9.精製水にて全量を100とする
[製造方法]成分3〜6を加熱溶解して混合し、70℃に保ち油相とする。成分1、2及び7〜9を加熱溶解して混合し、75℃に保ち水相とする。油相に水相を加えて乳化して、かき混ぜながら30℃まで冷却して製品とする。
次に、本発明の効果を詳細に説明するため、実験例を挙げる。
Formulation Example 8 Ointment Formulation Formulation 1. 1. Hot water extract from above-ground part of ogi (Production Example 1) 0.01 part 50% 1,3-butylene glycol extract of aboveground part of ogi (Production Example 3) 0.5
3. Polyoxyethylene cetyl ether (30E.O.) 2.0
4). Glycerol monostearate 10.0
5. Liquid paraffin 5.0
6). Cetanol 6.0
7). Methyl paraoxybenzoate 0.1
8). Propylene glycol 10.0
9. [Production Method] Components 3 to 6 are heated and dissolved and mixed with purified water to a total amount of 100, and kept at 70 ° C. to obtain an oil phase. Ingredients 1, 2, and 7-9 are dissolved by heating and mixed, and kept at 75 ° C. to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify, and the mixture is cooled to 30 ° C. with stirring to obtain a product.
Next, experimental examples will be given to explain the effects of the present invention in detail.
実験例1 抗酸化作用(DPPHラジカル消去作用)
製造例1、2及び比較製造例1、2を試料として用い、フリーラジカルの一種であるDPPHラジカルの消去作用を測定した。比較対照として、アスコルビン酸を用いた。また、試料の安定性を確認するために、試料を40℃で2週間保存した後に同様に測定を行った。
Experimental Example 1 Antioxidant action (DPPH radical scavenging action)
Using Production Examples 1 and 2 and Comparative Production Examples 1 and 2 as samples, the scavenging action of DPPH radical, which is a kind of free radical, was measured. As a control, ascorbic acid was used. Further, in order to confirm the stability of the sample, the sample was stored at 40 ° C. for 2 weeks, and then the same measurement was performed.
各濃度の試料水溶液0.3mLに0.1mLの酢酸緩衝液(pH5.5)と0.4mLのエタノールと0.2mLの0.5mMのDPPH(diphenylpycrylhydrazyl)エタノール溶液を加え、37℃で30分間反応させた後、波長517nmにおける吸光度を測定した。各試料の消去率は、次の式で算出した。
消去率(%)=(1−試料吸光度/ブランク吸光度)×100
これらの試験結果を表1に示した。アスコルビン酸は40℃で2週間の保存により、DPPHラジカル消去作用が大きく減少したが、オウギ地上部の抽出物は消去作用に変化はなかった。また、オウギ根の抽出物よりも効果が高かった。以上のことから、オウギ地上部の抽出物は、安定で優れたDPPHラジカル消去作用を示した。
To 0.3 mL of the sample aqueous solution of each concentration, add 0.1 mL of acetate buffer (pH 5.5), 0.4 mL of ethanol, and 0.2 mL of 0.5 mM DPPH (diphenylcyclic hydrazyl) ethanol solution at 37 ° C. for 30 minutes. After the reaction, the absorbance at a wavelength of 517 nm was measured. The erasure rate of each sample was calculated by the following formula.
Erase rate (%) = (1-sample absorbance / blank absorbance) × 100
The test results are shown in Table 1. Ascorbic acid significantly decreased the DPPH radical scavenging action by storage at 40 ° C. for 2 weeks, but the extract of the above-ground part of ogi did not change the scavenging action. Moreover, the effect was higher than that of the extract of oat root. From the above, the extract of the above-ground part of ogi showed a stable and excellent DPPH radical scavenging action.
実験例2 B16マウスメラノーマを用いたメラニン生成抑制試験
製造例1、2及び比較製造例1、2を試料として用い、メラニン生成抑制作用を測定した。
Experimental Example 2 Melanin Production Inhibition Test Using B16 Mouse Melanoma Using Production Examples 1 and 2 and Comparative Production Examples 1 and 2 as samples, melanin production inhibitory action was measured.
マウスメラノーマ由来細胞株であるB16細胞を6cmディッシュに3×104個播種し、10%FBSを含むMEM with NEAAにて5%CO2、37℃条件下で5日間培養した。その時、それぞれの試料は、最終濃度を調整して添加した。次に、細胞をPBS(−)にて2回洗浄した後、PBS(−)1mLを加え、ラバーポリスマンにて集めた。遠心操作をして得られたペレットにPBS(−)0.5mLを加え、超音波破砕操作をしてペレットを溶解させた。タンパク定量はLowry法{Lowry,O.H.et al.,J.Biol.Chem.,193,265−275(1951)}により測定した。また、1mgタンパクあたりのメラニン量を測定する場合、タンパク定量用に取った残りの細胞破砕溶液に4N水酸化ナトリウム0.5mLを加え、60℃で2時間反応させた後O.D.475を測定し、検量線からメラニン定量を行った。データは1mgタンパクあたりのメラニン量を算出し、試料未添加のメラニン生成量をコントロールとし、コントロールに対する試料添加時のメラニン生成抑制量の値をメラニン抑制率とした。 B16 cells, a mouse melanoma-derived cell line, were seeded at 3 × 10 4 cells in a 6 cm dish, and cultured for 5 days in MEM with NEAA containing 10% FBS under 5% CO 2 and 37 ° C. conditions. At that time, each sample was added after adjusting the final concentration. Next, after the cells were washed twice with PBS (−), 1 mL of PBS (−) was added and collected with a rubber policeman. PBS (-) 0.5mL was added to the pellet obtained by centrifugation, and the pellet was dissolved by ultrasonic crushing operation. Protein quantification was performed using the Lowry method {Lowry, O .; H. et al. , J .; Biol. Chem. , 193, 265-275 (1951)}. When measuring the amount of melanin per mg protein, 0.5 mL of 4N sodium hydroxide was added to the remaining cell disruption solution taken for protein quantification and reacted at 60 ° C. for 2 hours. D. 475 was measured, and melanin was determined from the calibration curve. The data was calculated as the amount of melanin per mg protein, the amount of melanin not added to the sample was taken as a control, and the value of the amount of melanin inhibition when the sample was added relative to the control was taken as the melanin inhibition rate.
これらの実験結果を表2に示した。オウギ地上部の抽出物は、優れたメラニン生成抑制作用を示し、オウギ根の抽出物よりも高い効果を示した。 The results of these experiments are shown in Table 2. The above-ground extract of ogi showed an excellent inhibitory action on melanin production, and was more effective than the extract of ogi root.
実験例3 使用試験
処方例1の化粧水、処方例2のクリーム、比較例1の従来の化粧水及び比較例2の従来のクリームを用いて、女性20人(18〜49才)を対象に1ヶ月間の使用試験を行った。使用後、肌のシワ、タルミ及びシミ、ソバカス等の改善効果をアンケートにより判定した。
Experimental Example 3 Use Test For 20 women (18 to 49 years old) using the lotion of Formulation Example 1, the cream of Formulation Example 2, the conventional lotion of Comparative Example 1 and the conventional cream of Comparative Example 2. A one month use test was conducted. After use, the improvement effect of skin wrinkles, tarmi, stains, buckwheat, etc. was determined by a questionnaire.
これらの試験結果を表3及び表4に示した。オウギ地上部の抽出物を含有する皮膚外用剤は優れたシワ、タルミ及びシミ、ソバカスの改善作用を示した。なお、試験期間中、皮膚トラブルは一人もなく、安全性においても問題なかった。また、処方成分の劣化についても問題なかった。 These test results are shown in Tables 3 and 4. The external preparation for skin containing the extract of the upper part of the ogi showed excellent wrinkle, tarmi, stain and buckwheat improving actions. During the test period, there was no skin problem and there was no problem with safety. There was also no problem with the deterioration of the prescription ingredients.
処方例3〜8についても同様に使用試験を行ったところ、優れたシワ、タルミ、シミ、ソバカス等の改善作用を示した。
When the usage test was similarly conducted for Formulation Examples 3 to 8, excellent wrinkle, tarmi, stain, buckwheat and other improving effects were shown.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007202774A JP5184840B2 (en) | 2007-08-03 | 2007-08-03 | Topical skin preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007202774A JP5184840B2 (en) | 2007-08-03 | 2007-08-03 | Topical skin preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009035521A JP2009035521A (en) | 2009-02-19 |
JP5184840B2 true JP5184840B2 (en) | 2013-04-17 |
Family
ID=40437763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007202774A Active JP5184840B2 (en) | 2007-08-03 | 2007-08-03 | Topical skin preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5184840B2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010215535A (en) * | 2009-03-13 | 2010-09-30 | Maruzen Pharmaceut Co Ltd | Melanin production-inhibiting agent |
EP2484356A4 (en) * | 2009-09-30 | 2013-12-04 | Shiseido Co Ltd | Oral composition for reducing wrinkle formation |
CN106309911B (en) * | 2016-08-19 | 2021-01-22 | 上海家化联合股份有限公司 | Anti-aging traditional Chinese medicine composition and preparation method thereof |
CN109199907A (en) * | 2017-07-07 | 2019-01-15 | 怀特生技新药股份有限公司 | Radix Astragali extract is preparing the application in the composition for inhibiting melanin production |
KR102390837B1 (en) * | 2019-12-13 | 2022-04-26 | 대한민국 | Functional composition for antioxidation comprising extract of Astragalus membranaceus Bunge leaves fermented by lactic acid bacteria as an active ingredient |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000236837A (en) * | 1999-02-17 | 2000-09-05 | Seika En | Food prepared by using koto-sugi as main raw material and its preparation |
JP2003155236A (en) * | 2001-11-16 | 2003-05-27 | Japan Science & Technology Corp | Use of pterocarpan |
-
2007
- 2007-08-03 JP JP2007202774A patent/JP5184840B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2009035521A (en) | 2009-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009029734A (en) | External preparation for skin | |
JP2003081749A (en) | Skin care preparation | |
JP5184840B2 (en) | Topical skin preparation | |
JP2002121112A (en) | Skin care preparation | |
JP5138262B2 (en) | Topical skin preparation | |
JP5154835B2 (en) | Whitening cosmetics | |
JP2002121144A (en) | Skin care preparation | |
JP4824181B2 (en) | Topical skin preparation | |
JP4628604B2 (en) | Skin preparation | |
JP5144362B2 (en) | Topical skin preparation | |
JP5468866B2 (en) | Topical skin preparation | |
JP3452671B2 (en) | External preparation for skin | |
JP2003095857A (en) | Skin care preparation | |
JP5415216B2 (en) | Topical skin preparation | |
JP3930165B2 (en) | Topical skin preparation | |
JP6281761B2 (en) | External preparation or internal preparation containing Hidakami Sebaya extract | |
JP2001114664A (en) | Cosmetic | |
JP4224387B2 (en) | Topical skin preparation | |
JP5690149B2 (en) | External preparation or internal preparation | |
JP4402274B2 (en) | Topical skin preparation | |
JP4473439B2 (en) | Whitening agent | |
JP4698810B2 (en) | Topical skin preparation | |
JP2000319159A (en) | Skin preparation for external use | |
JP3930179B2 (en) | Topical skin preparation | |
JP6433678B2 (en) | External preparations and internal preparations containing the extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100621 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120904 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120920 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130115 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130117 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5184840 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160125 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |